caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1760607808

David Barzilai

DermatologyWinchester, MAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
PRESCRIBING · PART D · 2024
Total Rx claims
98
Beneficiaries
—
Total drug cost
$2K
Distinct drugs
4
Brand share
0.0%
Top prescribed drugs
Mupirocin34 claims
Triamcinolone Acetonide28 claims
Metronidazole23 claims
Ketoconazole13 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$50
Payment records
2
By payment type
Food and Beverage$50
REFERRAL NETWORK

Where David Barzilai's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
BAYSTATE MEDICAL CENTER INC112220
THE MERCY HOSPITAL INC3556
Aimee Leonard
Dermatology · Stoneham, MA
2460
WENNER, NADINE20124
Sheila Mcmurrich
Dermatology · Springfield, MA
1520
O'NEILL, JOHN1429
Quest Diagnostics Massachusetts Llc
Clinical Laboratory · Marlborough, MA
1220
COOLEY DICKINSON HOSPITAL INC1119
Barbara Greco
Internal Medicine · Springfield, MA
1150
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.